HB0036

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB0036, covering 2025-01-03 to 2025-01-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]